Is there a relationship between beginning time and efficiency of octreotide in the treatment of experimental acute pancreatitis?
- PMID: 22563536
- PMCID: PMC3341478
- DOI: 10.4174/jkss.2012.82.5.296
Is there a relationship between beginning time and efficiency of octreotide in the treatment of experimental acute pancreatitis?
Abstract
Purpose: The efficacy of octreotide in the treatment of acute pancreatitis is controversial. Octreotide treatment for acute pancreatitis often shows poor correlation between results obtained in experimental studies and results of clinical trials. In a clinical setting, there is always a delay between the onset of the disease and initiation of the octreotide treatment. The aim of this study is to investigate the relationship between the beginning of treatment and alteration in effectiveness of octreotide.
Methods: Acute pancreatitis was induced by pancreatic duct ligation in 50 rats. The rats were randomly divided into five groups. Octreotide was not used in group 1 (control group). Only single dose (4 µg/kg) octreotide was administered subcutaneously to rats in group 2, having induced pancreatitis. Octreotide treatment was begun at different times (8th, 24th, 48th hour) in three other groups and continued treatment at a dosage of 4 µg/kg t.i.d. The animals were sacrificed at the end of the 72nd hour and blood and tissue samples were collected.
Results: Leukocyte count and plasma amylase values were less in groups 2 and 3. Hemorrhagic focuses were encountered less at pancreas tissues in group 3. Pancreatic necrosis and alveolar capillary basal membrane damage were lower in groups 3 and 4. No difference was found in fasting blood glucose, calcium and hematocrit.
Conclusion: Octreotide had benefical effects in acute pancreatitis when octreotide treatment was begun in the first 24 hours.
Keywords: Amylase; Octreotide; Pancreatitis.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
High dose octreotide in the management of acute pancreatitis.Hepatogastroenterology. 1999 May-Jun;46(27):1968-72. Hepatogastroenterology. 1999. PMID: 10430379 Clinical Trial.
-
Effects of delayed administration of octreotide in acute experimental pancreatitis.J Surg Res. 1996 Apr;62(1):109-17. doi: 10.1006/jsre.1996.0182. J Surg Res. 1996. PMID: 8606496
-
Octreotide: effects in experimental severe acute pancreatitis. Analysis of survival, biochemical findings and histomorphometry.Rev Esp Enferm Dig. 1997 Feb;89(2):101-15. Rev Esp Enferm Dig. 1997. PMID: 9115817 English, Spanish.
-
Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.Gut. 1994;35(3 Suppl):S15-9. doi: 10.1136/gut.35.3_suppl.s15. Gut. 1994. PMID: 7911442 Free PMC article. Review.
-
Potential role of somatostatin and octreotide in the management of acute pancreatitis.Digestion. 1994;55 Suppl 1:16-9. doi: 10.1159/000201183. Digestion. 1994. PMID: 7907565 Review.
Cited by
-
Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice.Int J Clin Exp Med. 2015 Oct 15;8(10):17551-64. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770346 Free PMC article.
References
-
- Yeo CI, Cameron JL. The pancreas. In: Sabiston DC, Lyerly HK, editors. Textbook of surgery: the biological basis of modern surgical practice. 15th ed. Philadelphia: WB Saunders; 1997. pp. 1152–1186.
-
- Steer ML. Acute pancreatitis. In: Yamada T, Alpers DH, editors. Textbook of gastroenterology. Philadelphia: Lippincott; 1991. pp. 1859–1873.
-
- Calleja GA, Barkin JS. Acute pancreatitis. Med Clin North Am. 1993;77:1037–1056. - PubMed
-
- Doherty MG, Way LW. Pancreas. In: Way LW, Doherty MG, editors. Current surgical diagnosis and treatment. New York: McGraw-Hill; 2003. pp. 625–651.
-
- Choi JY, Kim KH. Effects of small molecular antioxidants on cerulein-induced acute pancreatitis in rat. Korean J Physiol Pharmacol. 1998;2:629–635.
LinkOut - more resources
Full Text Sources